rs13228827

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The ENST00000788220.1(ENSG00000302625):​n.24G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.705 in 969,208 control chromosomes in the GnomAD database, including 242,739 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.73 ( 40222 hom., cov: 33)
Exomes 𝑓: 0.70 ( 202517 hom. )

Consequence

ENSG00000302625
ENST00000788220.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.438

Publications

7 publications found
Variant links:
Genes affected
NT5C3A (HGNC:17820): (5'-nucleotidase, cytosolic IIIA) This gene encodes a member of the 5'-nucleotidase family of enzymes that catalyze the dephosphorylation of nucleoside 5'-monophosphates. The encoded protein is the type 1 isozyme of pyrimidine 5' nucleotidase and catalyzes the dephosphorylation of pyrimidine 5' monophosphates. Mutations in this gene are a cause of hemolytic anemia due to uridine 5-prime monophosphate hydrolase deficiency. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and pseudogenes of this gene are located on the long arm of chromosomes 3 and 4. [provided by RefSeq, Mar 2012]
NT5C3A Gene-Disease associations (from GenCC):
  • hemolytic anemia due to pyrimidine 5' nucleotidase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 7-33062902-G-A is Benign according to our data. Variant chr7-33062902-G-A is described in ClinVar as Benign. ClinVar VariationId is 1295988.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.781 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NT5C3ANM_001002010.5 linkc.-197C>T upstream_gene_variant ENST00000610140.7 NP_001002010.2 Q9H0P0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NT5C3AENST00000610140.7 linkc.-197C>T upstream_gene_variant 1 NM_001002010.5 ENSP00000476480.2 X6RM59

Frequencies

GnomAD3 genomes
AF:
0.725
AC:
110115
AN:
151860
Hom.:
40175
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.788
Gnomad AMI
AF:
0.503
Gnomad AMR
AF:
0.748
Gnomad ASJ
AF:
0.568
Gnomad EAS
AF:
0.631
Gnomad SAS
AF:
0.621
Gnomad FIN
AF:
0.760
Gnomad MID
AF:
0.618
Gnomad NFE
AF:
0.703
Gnomad OTH
AF:
0.696
GnomAD4 exome
AF:
0.702
AC:
573380
AN:
817230
Hom.:
202517
AF XY:
0.698
AC XY:
293330
AN XY:
420454
show subpopulations
African (AFR)
AF:
0.805
AC:
16150
AN:
20066
American (AMR)
AF:
0.799
AC:
24578
AN:
30744
Ashkenazi Jewish (ASJ)
AF:
0.570
AC:
10677
AN:
18732
East Asian (EAS)
AF:
0.648
AC:
21308
AN:
32872
South Asian (SAS)
AF:
0.636
AC:
38618
AN:
60732
European-Finnish (FIN)
AF:
0.758
AC:
24235
AN:
31984
Middle Eastern (MID)
AF:
0.625
AC:
1794
AN:
2870
European-Non Finnish (NFE)
AF:
0.705
AC:
409498
AN:
580552
Other (OTH)
AF:
0.686
AC:
26522
AN:
38678
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
9097
18194
27290
36387
45484
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7612
15224
22836
30448
38060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.725
AC:
110220
AN:
151978
Hom.:
40222
Cov.:
33
AF XY:
0.727
AC XY:
53975
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.788
AC:
32645
AN:
41430
American (AMR)
AF:
0.748
AC:
11440
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.568
AC:
1966
AN:
3464
East Asian (EAS)
AF:
0.630
AC:
3234
AN:
5130
South Asian (SAS)
AF:
0.623
AC:
3002
AN:
4820
European-Finnish (FIN)
AF:
0.760
AC:
8050
AN:
10592
Middle Eastern (MID)
AF:
0.623
AC:
182
AN:
292
European-Non Finnish (NFE)
AF:
0.703
AC:
47781
AN:
67944
Other (OTH)
AF:
0.693
AC:
1463
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
1490
2980
4471
5961
7451
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
836
1672
2508
3344
4180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.664
Hom.:
2394
Bravo
AF:
0.726
Asia WGS
AF:
0.628
AC:
2184
AN:
3472

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
3.5
DANN
Benign
0.89
PhyloP100
-0.44
PromoterAI
0.027
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13228827; hg19: chr7-33102514; API